Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2014 (2014), Article ID 480463, 12 pages
http://dx.doi.org/10.1155/2014/480463
Review Article

Gram-Negative Infections in Adult Intensive Care Units of Latin America and the Caribbean

1Pulmonary Division, Department of Medicine, José de San Martin Hospital, University of Buenos Aires, Arenales 2557, Piso 1, Dep. A, 1425 Buenos Aires, Argentina
2Hospital Civil de Guadalajara “Fray Antonio Alcalde” and Institute of Infectious and Experimental Pathology, University Center of Health Sciences, University of Guadalajara, Guadalajara, JAL, Mexico
3Clinica Reñaca, Viña Del Mar, Chile
4Private Hospital Medical Center of Caracas and Vargas Hospital of Caracas, Caracas, Venezuela

Received 13 May 2014; Revised 2 November 2014; Accepted 4 November 2014; Published 27 November 2014

Academic Editor: Ali A. El-Solh

Copyright © 2014 Carlos M. Luna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Ibsen, “The anaesthetist's viewpoint on the treatment of respiratory complications in poliomyelitis during the epidemic in Copenhagen, 1952,” Proceedings of the Royal Society of Medicine, vol. 47, no. 1, pp. 72–74, 1954. View at Google Scholar · View at Scopus
  2. C. Brun-Buisson, F. Doyon, J. Carlet et al., “Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units,” Journal of the American Medical Association, vol. 274, no. 12, pp. 968–974, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. W. R. Jarvis, J. R. Edwards, D. H. Culver et al., “Nosocomial infection rates in adult and pediatric intensive care units in the United States,” The American Journal of Medicine, vol. 91, no. 3, supplement 2, pp. S185–S191, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Richards, J. R. Edwards, D. H. Culver, and R. P. Gaynes, “Nosocomial infections in combined medical-surgical intensive care units in the United States,” Infection Control and Hospital Epidemiology, vol. 21, no. 8, pp. 510–515, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Vincent, J. Rello, J. Marshall et al., “International study of the prevalence and outcomes of infection in intensive care units,” Journal of the American Medical Association, vol. 302, no. 21, pp. 2323–2329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Brun-Buisson, P. Meshaka, P. Pinton, and B. Vallet, “EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units,” Intensive Care Medicine, vol. 30, no. 4, pp. 580–588, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Finfer, R. Bellomo, J. Lipman et al., “Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units,” Intensive Care Medicine, vol. 30, no. 4, pp. 589–596, 2004. View at Publisher · View at Google Scholar
  8. A. Kohlenberg, F. Schwab, C. Geffers, M. Behnke, H. Rüden, and P. Gastmeier, “Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005,” Clinical Microbiology and Infection, vol. 14, no. 1, pp. 93–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, “The epidemiology of sepsis in the United States from 1979 through 2000,” The New England Journal of Medicine, vol. 348, no. 16, pp. 1546–1554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Padkin, C. Goldfrad, A. R. Brady, D. Young, N. Black, and K. Rowan, “Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland,” Critical Care Medicine, vol. 31, no. 9, pp. 2332–2338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Silva, M. A. Pedro, A. C. B. Sogayar et al., “Brazilian sepsis epidemiological study (BASES study),” Critical Care, vol. 8, no. 4, pp. R251–R260, 2004. View at Publisher · View at Google Scholar
  12. World Health Organization, Report on the Burden of Endemic Health Care-Associated Infection Worldwide, World Health Organization, 2011, http://whqlibdoc.who.int/publications/2011/9789241501507_eng.pdf.
  13. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. I. Hidron, J. R. Edwards, J. Patel et al., “Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007,” Infection Control and Hospital Epidemiology, vol. 29, no. 11, pp. 996–1011, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. B. Tognim, S. S. Andrade, S. Silbert, A. C. Gales, R. N. Jones, and H. S. Sader, “Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program,” International Journal of Infectious Diseases, vol. 8, no. 5, pp. 284–291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. G. R. Lossa, R. G. Lerena, L. E. Fernández et al., “Prevalence of hospital infections in adult intensive care units in Argentina,” Revista Panamericana de Salud Publica, vol. 24, no. 5, pp. 324–330, 2008. View at Google Scholar · View at Scopus
  17. C. M. Luna, D. Blanzaco, M. S. Niederman et al., “Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome,” Critical Care Medicine, vol. 31, no. 3, pp. 676–682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Toufen Junior, A. L. D. Hovnanian, S. A. Franca, and C. R. R. Carvalho, “Prevalence rates of infection in intensive care units of a tertiary teaching hospital.,” Revista do Hospital das Clínicas., vol. 58, no. 5, pp. 254–259, 2003. View at Google Scholar · View at Scopus
  19. M. de Queiroz Guimarães and J. R. Rocco, “Prevalence of ventilator-associated pneumonia in a university hospital and prognosis for the patients affected,” Jornal Brasileiro de Pneumologia, vol. 32, no. 4, pp. 339–346, 2006. View at Google Scholar · View at Scopus
  20. M. E. Lima, D. de Andrade, and V. J. Haas, “Prospective assessment of the occurrence of infection in critical patients in an intensive care unit,” Revista Brasileira de Terapia Intensiva, vol. 19, pp. 342–347, 2007 (Portuguese). View at Google Scholar
  21. L. D. A. da Rocha, C. A. P. Vilela, R. C. Cezário, A. B. Almeida, and P. Gontijo Filho, “Ventilator-associated pneumonia in an adult clinical-surgical intensive care unit of a Brazilian University Hospital: incidence, risk factors, etiology, and antibiotic resistance,” Brazilian Journal of Infectious Diseases, vol. 12, no. 1, pp. 80–85, 2008. View at Google Scholar · View at Scopus
  22. P. M. D. A. Rodrigues, E. do Carmo Neto, L. R. D. C. Santos, and M. F. Knibel, “Ventilator-associated pneumonia: epidemiology and impact on the clinical evolution of ICU patients,” Jornal Brasileiro de Pneumologia, vol. 35, no. 11, pp. 1084–1091, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. C. de Oliveira, R. S. Silva, M. E. P. Díaz, and R. A. Iquiapaza, “Bacterial resistance and mortality in an intensive care unit,” Revista Latino-Americana de Enfermagem, vol. 18, no. 6, pp. 1152–1160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Zaidi, J. Sifuentes-Osornio, A. L. Rolón et al., “Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit,” Archives of Medical Research, vol. 33, no. 3, pp. 290–294, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. F. G. Rios, C. M. Luna, B. Maskin et al., “Ventilator-associated pneumonia due to colistin susceptible-only microorganisms,” European Respiratory Journal, vol. 30, no. 2, pp. 307–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. H. C. Furtado, M. D. Bergamasco, F. G. Menezes et al., “Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: Risk factors and mortality,” Journal of Critical Care, vol. 24, no. 4, pp. 625.e9–625.e14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. H. Furtado, A. C. Gales, L. B. Perdiz, A. F. Santos, S. B. Wey, and E. A. Medeiros, “Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit,” Anaesthesia and Intensive Care, vol. 38, no. 6, pp. 994–1001, 2010. View at Google Scholar · View at Scopus
  28. B. Weyland, B. Perazzi, S. Garcia, C. Rodríguez, C. Vay, and A. Famiglietti, “Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment,” Revista Argentina de Microbiologia, vol. 43, no. 1, pp. 18–23, 2011. View at Google Scholar · View at Scopus
  29. C. M. Figueiredo-Mendes, S. Sinto, J. L. Mello-Sampaio et al., “Pseudomonas aeruginosa clonal dissemination in Brazilian intensive care units,” Enfermedades Infecciosas y Microbiología Clínica, vol. 23, no. 7, pp. 402–405, 2005. View at Google Scholar
  30. A. C. Gales, P. L. Torres, D. S. O. Vilarinho, R. S. Melo, C. F. L. Silva, and R. F. Cereda, “Carbapenem-resistant Pseudomonas aeruginosa outbreak in an intensive care unit of a teaching hospital,” The Brazilian Journal of Infectious Diseases, vol. 8, no. 4, pp. 267–271, 2004. View at Google Scholar · View at Scopus
  31. R. C. Cezário, L. Duarte De Morais, J. C. Ferreira, R. M. Costa-Pinto, A. L. Da Costa Darini, and P. P. Gontijo-Filho, “Nosocomial outbreak by imipenem-resistant metallo-β-lactamase-producing pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital,” Enfermedades Infecciosas y Microbiologia Clinica, vol. 27, no. 5, pp. 269–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Córdova, M. I. Lespada, N. Gómez, F. Pasterán, V. Oviedo, and C. Rodríguez-Ismael, “Clinical and epidemiological study of an outbreak of KPC-producing Klebsiella pneumoniae infection in Buenos Aires, Argentina,” Enfermedades Infecciosas y Microbiología Clínica, vol. 30, no. 7, pp. 376–379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. R. Marra, L. F. A. Camargo, A. C. C. Pignatari et al., “Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study,” Journal of Clinical Microbiology, vol. 49, no. 5, pp. 1866–1871, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. R. Bustamante and V. E. Solar, Informe de vigilancia epidemiológica de infecciones intrahospitalarias, Ministry of Health (Chile), 2007, http://web.minsal.cl/portal/url/item/73627aa2edca0374e04001011f01734d.pdf.
  35. M. Medell, A. Martínez, and R. Valdés, “Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units,” Brazilian Journal of Infectious Diseases, vol. 16, no. 1, pp. 45–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Venezuela, “Programa venezolano de vigilancia de la resistencia bacteriana a los antimicrobianos,” 2013, http://www.provenra.org/.
  37. F. G. Rubio, V. D. C. Oliveira, R. M. C. Rangel, M. C. L. Nogueira, and M. T. G. Almeida, “Trends in bacterial resistance in a tertiary university hospital over one decade,” Brazilian Journal of Infectious Diseases, vol. 17, no. 4, pp. 480–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. F. O. Silva, M. Cifuentes, and E. C. Pinto, “Results of antimicrobial susceptibility surveillance in Chile: consolidating a network,” Revista Chilena de Infectología, vol. 28, no. 1, pp. 19–27, 2011 (Spanish). View at Google Scholar
  39. D. F. Briceño, A. Correa, C. Valencia et al., “Antimicrobial resistance of Gram negative bacilli isolated from terciary-care hospitals in Colombia,” Biomedica, vol. 30, no. 3, pp. 371–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. P. V. Rodríguez, M. H. D. Ortega, L. I. B. Garzón et al., “Trends of bacterial resistance phenotypes in high-complexity public and private hospitals in Colombia,” Revista Panamericana de Salud Publica, vol. 30, no. 6, pp. 627–633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Medell, M. Hart, O. Marrero, F. Espinosa, Z. Montes de Oca, and R. Valdés, “Clinical and microbiological characterization of pneumonia in mechanically ventilated patients,” Brazilian Journal of Infectious Diseases, vol. 16, no. 5, pp. 442–447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. F. A. Orrett, “Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies,” Saudi Medical Journal, vol. 25, no. 4, pp. 478–483, 2004. View at Google Scholar · View at Scopus
  43. C. M. Luna, P. Aruj, M. S. Niederman et al., “Appropriateness and delay to initiate therapy in ventilator-associated pneumonia,” European Respiratory Journal, vol. 27, no. 1, pp. 158–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. E. V. Lemos, F. De La Hoz Restrepo, N. Alvis, E. Quevedo, O. Cañon, and Y. León, “Acinetobacter baumanniirelated mortality in intensive care units in Colombia,” Revista Panamericana de Salud Publica, vol. 30, no. 4, pp. 287–294, 2011. View at Google Scholar · View at Scopus
  45. J. A. Labarca, M. J. Salles, C. Seas, and M. Guzmán-Blanco, “Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America,” Critical Reviews in Microbiology, 2014. View at Publisher · View at Google Scholar
  46. M. Guzmán-Blanco, J. A. Labarca, M. V. Villegas, and E. Gotuzzo, “Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America,” The Brazilian Journal of Infectious Diseases, vol. 18, no. 4, pp. 421–433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. R. E. Barbolla, D. Centrón, S. Maimone et al., “Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting,” The American Journal of Infection Control, vol. 36, no. 6, pp. 444–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. A. C. Gales, R. N. Jones, K. R. Forward, J. Liñares, H. S. Sader, and J. Verhoef, “Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999),” Clinical Infectious Diseases, vol. 32, no. 10, pp. S104–S113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. A. C. Gales, R. N. Jones, J. Turnidge, R. Rennie, and R. Ramphal, “Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997–1999,” Clinical Infectious Diseases, vol. 32, supplement 2, no. 10, pp. S146–S155, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. R. P. Dellinger, M. M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012,” Critical Care Medicine, vol. 41, no. 2, pp. 580–637, 2013. View at Publisher · View at Google Scholar
  51. P. Pronovost, D. Needham, S. Berenholtz et al., “An intervention to decrease catheter-related bloodstream infections in the ICU,” The New England Journal of Medicine, vol. 355, no. 26, pp. 2725–2732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. P. J. Pronovost, C. A. Goeschel, E. Colantuoni et al., “Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study,” British Medical Journal, vol. 340, article c309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Resar, P. Pronovost, C. Haraden, T. Simmonds, T. Rainey, and T. Nolan, “Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia,” The Joint Commission Journal on Quality and Patient Safety, vol. 31, no. 5, pp. 243–248, 2005. View at Google Scholar · View at Scopus
  54. A. B. Haynes, T. G. Weiser, W. R. Berry et al., “A surgical safety checklist to reduce morbidity and mortality in a global population,” The New England Journal of Medicine, vol. 360, no. 5, pp. 491–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. World Health Organization, WHO Guidelines for Safe Surgery 2009, WHO, 2009, http://whqlibdoc.who.int/publications/2009/9789241598552_eng.pdf.
  56. T. F. O'Brien and J. Stelling, “Integrated multilevel surveillance of the world's infecting microbes and their resistance to antimicrobial agents,” Clinical Microbiology Reviews, vol. 24, no. 2, pp. 281–295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. G. A. Jacoby, “AmpC β-lactamases,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 161–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Nordmann, G. Cuzon, and T. Naas, “The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria,” The Lancet Infectious Diseases, vol. 9, no. 4, pp. 228–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. V. Villegas, K. Lolans, A. Correa et al., “First detection of the plasmid-mediated class a carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 8, pp. 2880–2882, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Alvarez-Lerma, A. Martinez Pellus, B. Alvarez Sánchez et al., “Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit,” Intensive Care Medicine, vol. 22, no. 5, pp. 387–394, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. C. M. Luna, S. Sarquis, M. S. Niederman et al., “Is a strategy based on routine endotracheal cultures the best way to prescribe antibiotics in ventilator-associated pneumonia?” Chest, vol. 144, no. 1, pp. 63–71, 2013. View at Publisher · View at Google Scholar
  62. American Thoracic Society and Infectious Diseases Society of America, “Guidelines for the management of a dults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 4, pp. 388–416, 2005. View at Publisher · View at Google Scholar
  63. T. H. Dellit, R. C. Owens, J. E. McGowan Jr. et al., “Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship,” Clinical Infectious Diseases, vol. 44, no. 2, pp. 159–177, 2007. View at Google Scholar
  64. C. MacDougall and R. E. Polk, “Antimicrobial stewardship programs in health care systems,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 638–656, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Fishman, “Antimicrobial stewardship,” The American Journal of Medicine, vol. 119, supplement 1, no. 6, pp. S53–S61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. F. X. C. Salgado, J. C. Gonçalves, C. M. de Souza, N. B. da Silva, T. E. G. Sanchez, and M. G. de Oliveira Karnikowski, “Cost of antimicrobial treatment in patients infected with multidrug-resistant organisms in the intensive care unit,” Medicina, vol. 71, no. 6, pp. 531–535, 2011. View at Google Scholar · View at Scopus